Benjamin Weinberg, MD, FACP
@benweinbergmd
GI Medical Oncologist, Associate Professor of Medicine @Georgetown @RueschCenter @LombardiCancer, Ex-@SidwellFriends @Penn @KeckMedUSC keyboardist @BasementRiot
ID: 868221528
http://www.benweinberg.com 08-10-2012 15:59:42
2,2K Tweet
2,2K Followers
832 Following
#ctDNA Testing Could Lead to New Ways of Staging Cancer Patients, Says Benjamin Weinberg, MD, FACP, MedStar Georgetown University mendelspod.com/p/ctdna-testin… #colorectalcancer Cure GI Cancers Georgetown Lombardi #biomarker #personalizedmedicine
This week, we highlighted novel research by GU Medical Center investigators and their collaborators across the US and China, published in Cell Cycle. Learn more: bit.ly/3WM1Isn
The Agenus paper on Botensilimab with preclinical data, plus early phase trial with monotherapy & dual combo is on Cancer Discovery: Botensilimab, an Fc-enhanced anti-CTLA-4 antibody, is effective against tumors poorly responsive to conventional immunotherapy aacrjournals.org/cancerdiscover…
Congratulations Thejus Jayakrishnan Alok Khorana, MD and multi-institutional collaborative team on publication in JCO Precision Oncology of this work: "Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers." ascopubs.org/doi/full/10.12…
Aspirin Use, Lifestyle Factors, and Colorectal Cancer Incidence JAMA Oncology jamanetwork.com/journals/jamao…
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: ascopubs.org/doi/abs/10.120… @thejusjay Alok Khorana, MD #gicsm
Our latest data evaluate early-onset biliary cancer genomic profiles (yes, early onset isn't just CRC), led by Thejus Jayakrishnan and many collaborators nationwide Caris Life Sciences Cholangiocarcinoma Foundation
As we look forward to an impending FDA approval on 1L zolbetuximab, please join us for a discussion on CLDN18.2 in gastric cancer! Led by our outstanding CU Anschutz Hematology/Oncology Fellowship 3rd year heme/onc fellow Nicole Baranda Balmaceda, MD. CU Cancer Center
Registration for #GI25 is open! Join us for this incredible meeting with all of my favorite people! ASCO Robin Zon, MD, FACP, FASCO Emil Lou, MD, PhD, FACP Allison Rosen, MS University of Arizona Cancer Center url.usb.m.mimecastprotect.com/s/DOUfCEKLJEt3…
The study results suggest that orthogonal MS testing is critical to identify MSI-H in PC and patients with MSI-H PC should be treated with immune checkpoint blockade therapy. ja.ma/4gbePuZ Catherine O’Connor Eileen M O’Reilly
This year's #RueschSymposium Thomas R. Schafer Memorial Lecture features Dr. Anirban Maitra (Anirban Maitra) of MD Anderson Cancer Center on November 22, 2024, at 1:20 p.m. EST. Learn more and register today. bit.ly/Ruesch2024. Georgetown Lombardi MedStar Georgetown
Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 🔎POCHI trial 👉ORR 74%, DRC 100%, 5 CR 👉12-mo PFS rate 51% 👉2-yr OS rate 80% 👉AEs ≥3 70% 🧐IMMUNOSCORE and TuLIS score (18% of pts) to select ICI in mCRC? ESMO - Eur. Oncology #ESMOAmbassadors
Pleased to share final survival results of two phase 3 of zolbetuximab NEJM which reinforce zolbetuxumab plus chemo as effective treatment option, though still need better treatment. More agents will be coming for CLDN18.2+ GC ESMO - Eur. Oncology OncoAlert #ESMO24 nejm.org/doi/full/10.10…
Join us for the 15th Annual Ruesch Center Symposium on Nov 22-23! Session Topic: The Current Landscape of Therapies in Pancreatic and Other GI Cancers. Georgetown Lombardi MedStar Georgetown Dr. Shubham Pant #GIcancer Register today: bit.ly/Ruesch24
